Antipsychotic drug use in pregnancy: A multinational study from ten countries.

ABSTRACT:

Aim

To compare the prevalence and trends of antipsychotic drug use during pregnancy between countries across four continents.

Methods

Individually linked health data in Denmark (2000-2012), Finland (2005-2014), Iceland (2004-2017), Norway (2005-2015), Sweden (2006-2015), Germany (2006-2015), Australia (New South Wales, 2004-2012), Hong Kong (2001-2015), UK (2006-2016), and the US (Medicaid, 2000-2013, and IBM MarketScan, 2012-2015) were used. Using a uniformed approach, we estimated the prevalence of antipsychotic use as the proportion of pregnancies where a woman filled at least one antipsychotic prescription within three months before pregnancy until birth. For the Nordic countries, data were meta-analyzed to investigate maternal characteristics associated with the use of

SUBMITTER: Reutfors J 

PROVIDER: S-EPMC7306443 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature